California Health Watch: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on California Health Watch.

Press releases published on August 26, 2026

Aug. 26, 2026

Odyssey Therapeutics to Participate in Upcoming Investor Conferences

Indeterminate GlobeNewswire

Aug. 26, 2026

InnovAge Announces Conference Call to Discuss Fourth Quarter and Fiscal 2026 Financial Results and Participation in Upcoming Wells Fargo Healthcare Conference

Indeterminate GlobeNewswire

Aug. 26, 2026

Curonix LLC Appoints Healthcare and Financial Services Veteran Carlos A. Migoya to Board of Managers

Indeterminate GlobeNewswire

Aug. 26, 2026

Trevi Therapeutics Announces Upcoming Presentations at the European Respiratory Society (ERS) Congress 2026

Indeterminate GlobeNewswire

Aug. 26, 2026

Repligen Corporation to Present at Wells Fargo 21st Annual Healthcare Conference

Indeterminate GlobeNewswire

Aug. 26, 2026

BridgeBio Announces First Participant Dosed in ASCEND-ATTR, a Phase 3b/4 Study Evaluating the Long-Term Effects of Acoramidis on Disease Regression in ATTR-CM

Indeterminate GlobeNewswire

Aug. 26, 2026

Eikon Therapeutics to Participate in Investor Conferences in September 2026

Indeterminate GlobeNewswire

Aug. 26, 2026

MicrobiotiX Completes Sentinel Cohort of its First-in-human Clinical Trial of MP101 for Pneumonia

Indeterminate GlobeNewswire

Aug. 26, 2026

Wellness Together and TadHealth Partner to Expand Student Behavioral Health Support Through CYBHI

Indeterminate GlobeNewswire

Aug. 26, 2026

Radiopharm Theranostics Doses First Patient in Second Cohort of Phase 1/2a Clinical Trial of BetaBart (RV-01) in B7-H3 Expressing Solid Tumors

Indeterminate GlobeNewswire

Aug. 26, 2026

Ligand to Participate in September Investor Conferences

Indeterminate GlobeNewswire

Aug. 26, 2026

INmune Bio Advances Ebstrocel™ Toward European Marketing Authorization with EMA Regulatory Filings

Indeterminate GlobeNewswire

Aug. 26, 2026

Blood Cancer Therapeutics Market to Reach $125.5 Billion by 2030, Driven by Precision Medicine Advances and Expanding Immunotherapy Pipelines

Indeterminate GlobeNewswire

Aug. 26, 2026

Kestra Appoints Curtis Kopf as Senior Vice President of Customer Experience

Indeterminate GlobeNewswire

Aug. 26, 2026

Optical Sorter Global Market to Reach $5.4 Billion by 2030, Driven by AI-Powered Sorting Systems and Circular Economy Mandates

Indeterminate GlobeNewswire

Aug. 26, 2026

HepaRegeniX Receives Orphan Drug Designation for Darizmetinib for the Prevention of Post-Hepatectomy Liver Failure

Indeterminate GlobeNewswire

Aug. 26, 2026

Nxera Pharma’s Partner Neurocrine Biosciences Receives IND Acceptance from the FDA for Phase 2 Study of NBI-1117567 for Alzheimer's Cognition

Indeterminate GlobeNewswire

Aug. 26, 2026

4basebio and Genezen Enter into Strategic Collaboration to Advance Synthetic, Cell-Free DNA Platforms for Next-Generation Viral Vector Manufacturing

Indeterminate GlobeNewswire

Aug. 26, 2026

ADDEX raises USD 2.8 million through its ATM agreement and extends cash runway to the fourth quarter 2027

Indeterminate GlobeNewswire

Aug. 26, 2026

Testie Health Launches Nationwide to Make STI Testing Simpler, Faster, and Less Stigmatized

Indeterminate GlobeNewswire